Cover Image
市場調查報告書

肝腎症候群:全球臨床實驗檢討

Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 240557
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
肝腎症候群:全球臨床實驗檢討 Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月28日 內容資訊: 英文 83 Pages
簡介

本報告提供肝腎症候群相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7·E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,並彙整有潛力的藥劑比較等資訊。

簡介

  • 肝腎症候群
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區

G7各國的臨床實驗數量:肝腎症候群臨床實驗數量上消化管疾病臨床實驗數量所佔的比例

Phase別臨床實驗數量:G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:肝腎症候群臨床實驗數量上消化管疾病臨床實驗數量所佔的比例

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 肝腎症候群治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • La Jolla Pharmaceutical Company
    • Ferring International Center S.A.
    • Orphan Therapeutics, LLC
    • Novartis AG
    • Noorik Biopharmaceuticals AG
    • Max India Limited
    • Ikaria Holdings, Inc.
    • Curatis Pharma GmbH
    • Cumberland Pharmaceuticals, Inc.
  • 有代表性的研究機關/醫院臨床實驗概要
    • Hospital Clinic de Barcelona
    • University of Virginia
    • All India Institute of Medical Sciences
    • Austin Health
    • Azienda Ospedaliera di Padova
    • Charite - Universitatsmedizin Berlin
    • Fundacio Clinic per a la Recerca Biomedica
    • Isfahan University of Medical Sciences
    • Pomeranian Medical University
    • Postgraduate Institute of Medical Education and Research

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2659CTIDB

GlobalData's clinical trial report, "Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Hepatorenal Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatorenal Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatorenal Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hepatorenal Syndrome
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hepatorenal Syndrome
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hepatorenal Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • La Jolla Pharmaceutical Company
      • Clinical Trial Overview of La Jolla Pharmaceutical Company
      • Ferring International Center S.A.
      • Clinical Trial Overview of Ferring International Center S.A.
      • Orphan Therapeutics, LLC
      • Clinical Trial Overview of Orphan Therapeutics, LLC
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Noorik Biopharmaceuticals AG
      • Clinical Trial Overview of Noorik Biopharmaceuticals AG
      • Max India Limited
      • Clinical Trial Overview of Max India Limited
      • Ikaria Holdings, Inc.
      • Clinical Trial Overview of Ikaria Holdings, Inc.
      • Curatis Pharma GmbH
      • Clinical Trial Overview of Curatis Pharma GmbH
      • Cumberland Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cumberland Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Hospital Clinic de Barcelona
      • Clinical Trial Overview of Hospital Clinic de Barcelona
      • University of Virginia
      • Clinical Trial Overview of University of Virginia
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Austin Health
      • Clinical Trial Overview of Austin Health
      • Azienda Ospedaliera di Padova
      • Clinical Trial Overview of Azienda Ospedaliera di Padova
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Fundacio Clinic per a la Recerca Biomedica
      • Clinical Trial Overview of Fundacio Clinic per a la Recerca Biomedica
      • Isfahan University of Medical Sciences
      • Clinical Trial Overview of Isfahan University of Medical Sciences
      • Pomeranian Medical University
      • Clinical Trial Overview of Pomeranian Medical University
      • Postgraduate Institute of Medical Education and Research
      • Clinical Trial Overview of Postgraduate Institute of Medical Education and Research
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by La Jolla Pharmaceutical Company, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Orphan Therapeutics, LLC, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Noorik Biopharmaceuticals AG, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Max India Limited, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Curatis Pharma GmbH, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera di Padova, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Clinic per a la Recerca Biomedica, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pomeranian Medical University, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015*

List of Figures

  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top